Pharmaceutical pot for pain
Well they're finally admitting that cannabis has medicinal properties. New scientific studies prove that a cannabinoid receptor in the plant is shown to inhibit acute, inflammatory, and neuropathic pain. Anecdotal evidence proves that pharmaceutical companies have known right along and have merely been waiting to figure out how to make money from it before they endorse it.
Johnson & Johnson sponsored this study and here's the rub. They figure you have to take the high out of the plant in order for it to be socially acceptable. Thus these studies are working on a process to do just that. As the article so obliquely puts it, "Extricating the high could aid in generating novel pharmaceuticals free of the political opposition facing medical marijuana." In other words, they'll be for it when they can turn the plant into a chemical that can only be obtained through them.
I would note that J & J, along with most if not all big pharma corps are huge sponsors of prohibition under the guise of such agencies as Partnership for a Drug Free America. They will no doubt continue to support medical marijuana prohibition in the interim of course, proving once again that they are always willing to put profits over the pain and suffering of the people.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home